Clinical trials
Active, not recruiting Burkitt Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 50 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 8 |
| City of Hope Medical Center | 7 |
| Memorial Sloan Kettering Cancer Center | 4 |
| Children's Oncology Group | 3 |
| M.D. Anderson Cancer Center | 2 |
| Novartis Pharmaceuticals | 2 |
| Stanford University | 2 |
| AIDS Malignancy Consortium | 1 |
| Alliance for Clinical Trials in Oncology | 1 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 50 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 16 |
| Lymphoma, Large B-Cell, Diffuse | 11 |
| Lymphoma, Non-Hodgkin | 10 |
| Lymphoma, B-Cell | 8 |
| Lymphoma, B-Cell, Marginal Zone | 8 |
| Lymphoma, Follicular | 8 |
| Lymphoma, Mantle-Cell | 8 |
| Leukemia, Biphenotypic, Acute | 7 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 7 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.